Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Aug 1;20(15):3757.
doi: 10.3390/ijms20153757.

Therapeutic Effects of Curcumin-From Traditional Past to Present and Future Clinical Applications

Affiliations
Editorial

Therapeutic Effects of Curcumin-From Traditional Past to Present and Future Clinical Applications

Beatrice E Bachmeier et al. Int J Mol Sci. .

Abstract

The efficacy of the plant-derived polyphenol curcumin, in various aspects of health and wellbeing, are a matter of public interest. An internet search of the term "Curcumin" displays about 12 million hits. Among the multitudinous information presented on partly doubtful websites, there are reports attracting the reader with promises ranging from eternal youth to cures for incurable diseases. Unfortunately, many of these reports are not based on scientific evidence, but they feed the desideratum of the reader for a "miracle cure". This circumstance makes it very difficult for researchers, whose work is scientifically sound and evidence is based on the therapeutic benefits (or side effects) of curcumin, to demarcate their results from sensational reports that circulate in the web and in other media. This is only one of many obstacles making it difficult to pave curcumin's way into clinical application; others are its nonpatentability and low economic usability. A further impediment comes from scientists who never worked with curcumin or any other natural plant-derived compound in their own labs. They have never tested these compounds in any scientific assay, neither in vitro nor in vivo; however, they claim, in a sometimes polemic manner, that everything that has so far been published on curcumin's molecular effects is based on artefacts. The here presented Special Issue comprises a collection of five scientifically sound articles and nine reviews reporting on the therapeutic benefits and the molecular mechanisms of curcumin or of chemically modified curcumin in various diseases ranging from malignant tumors to chronic diseases, microbial infection, and even neurodegenerative diseases. The excellent results of the scientific projects that underlie the five original papers give reason to hope that curcumin will be part of novel treatment strategies in the near future-either as monotherapy or in combination with other drugs or therapeutic applications.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: A component of tumeric [Curcuma longa] J. Altern. Complement. Med. 2003;9:161–168. doi: 10.1089/107555303321223035. - DOI - PubMed
    1. Bachmeier B.E., Killian P., Pfeffer U., Nerlich A.G. Novel aspects for the application of Curcumin in chemoprevention of various cancers. Front. Biosci. 2010;2:697–717. doi: 10.2741/s95. - DOI - PubMed
    1. Kronski E., Fiori M.E., Barbieri O., Astigiano S., Mirisola V., Killian P.H., Bruno A., Pagani A., Rovera F., Pfeffer U., et al. miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2. Mol. Oncol. 2014;8:581–595. doi: 10.1016/j.molonc.2014.01.005. - DOI - PMC - PubMed
    1. Bachmeier B.E., Killian P.H., Melchart D. The Role of Curcumin in Prevention and Management of Metastatic Disease. Int. J. Mol. Sci. 2018;19:1716. doi: 10.3390/ijms19061716. - DOI - PMC - PubMed
    1. Killian P.H., Kronski E., Michalik K.M., Barbieri O., Astigiano S., Sommerhoff C.P., Pfeffer U., Nerlich A.G., Bachmeier B.E. Curcumin inhibits prostate cancer metastasis in vivo by targeting the inflammatory cytokines CXCL1 and -2. Carcinogenesis. 2012;33:2507–2519. doi: 10.1093/carcin/bgs312. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources